69 Best Startups in Basel to Watch in 2024

Novel antiobiotic researcher to fight antimicrobial resistance.

Total Raised: $34.47M

Last Funding: $13.57M (Series C)

Clinical-stage central nervous system (CNS) technology.

Total Raised: $169.29M

Last Funding: $110.29M (Series B)

Viral vector-based cancer vaccines developer.

Total Raised: $141.79M

Last Funding: $82.89M (Series C)

Therapeutics developer for mast cell-mediated diseases.

Total Raised: $3.50M

Last Funding: $3.50M (Seed)

Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders.

Total Raised: $50.00M

Last Funding: $50.00M (Series A)

Healthcare procurement platform.

Total Raised: $2.00M

Last Funding: $2.00M (Seed)

Clinically tested, patent-protected dietary therapy for migraines.

Total Raised: $4.80M

Last Funding: $4.80M (Seed)

True precision medicine through single-cell science

Total Raised: $5.90M

Last Funding: $1.80M (Series A)

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

Total Raised: $30.00M

Last Funding: $30.00M (Series A)

Treatments that improve the lives of cancer patients with innovative approaches.

Total Raised: $26.73M

Last Funding: $26.73M (Series C)

Clinical biotech firm focused on revolutionizing cell invasion research.

Total Raised: $4.70M

Last Funding: $4.70M (Seed)

Platform engineering next-generation T cell receptor therapies.

Total Raised: $15.80M

Last Funding: $15.80M (Seed)

Automated visual inspection for pharma.

Total Raised: $0.88M

Last Funding: $0.88M (Seed)

Antibiotic resistance test.

Total Raised: $9.17M

Last Funding: $9.17M (Series B)

Quantum sensing technology for nanoscale imaging.

Total Raised: $7.08M

Last Funding: $4.46M (Series A)

Platform focusing on the discovery and development of next-generation RNA-based drugs.

Total Raised: $6.42M

Last Funding: $6.42M (Seed)

Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations.

Total Raised: $3.90M

Last Funding: $3.90M (Pre Seed)

Developer of oral therapeutics to treat complex autoimmune diseases.

Total Raised: $3.50M

Last Funding: $3.50M (Seed)

Platform for renting campers directly from private owners.

Total Raised: $1.43M

Last Funding: $0.00M (Unknown)

Solutions that advance neuroscience research and speed up preclinical drug discovery.

Total Raised: $4.50M

Last Funding: $4.50M (Series A)

Digital therapies for Alzheimer's disease.

Total Raised: $4.32M

Last Funding: $4.32M (Seed)

Preventive health technology.

Total Raised: $4.27M

Last Funding: $4.27M (Pre Seed)

Preclinical-stage oncology platform.

Total Raised: $1.40M

Last Funding: $1.40M (Seed)

Biotechnology company developing treatments to enhance immune system responses.

Total Raised: $0.15M

Last Funding: $0.15M (Pre Seed)

Pioneering value & data-driven healthcare for patients

Total Raised: $0.99M

Last Funding: $0.99M (Seed)

Next-gen IgV therapeutics developer.

Total Raised: $0.66M

Last Funding: $0.66M (Pre Seed)

Platform for community-based second opinions, booking health services, and managing travel logistics worldwide.

Total Raised: $0.50M

Last Funding: $0.50M (Seed)

Platform analyzing doctors' statistics and indicators to address rising healthcare costs.

Total Raised: $0.21M

Last Funding: $0.21M (Pre Seed)

We are on a mission to make grocery shopping waste-free.

Total Raised: $0.23M

Last Funding: $0.00M (Unknown)

Reshaping the future of healthcare

Total Raised: $0.26M

Last Funding: $0.26M (Pre Seed)

Developer of oral therapeutics to treat complex autoimmune diseases.

Fractal Flows is a blockchain company founded in 2015 by Imad Abdallah.

Clinical stage R&D company developing therapies to control and modulate pathogenic gene expression.

Last Funding: $0.00M (Unknown)

Proprietary chemical protein synthesis and conjugation platform.

Invaio is a Cambridge, Massachusetts-based biotechnology company founded by Ignacio Martinez.